Submit Deal

ROCK SPRINGS CAPITAL

HQ - Baltimore, Maryland

Summary

Rock Springs Capital is an investment company located in Baltimore, Maryland.

Deals Overview

Total Deals25

Valued Deals24

Total Value£ 6.60 B

Avg. Deal Size£ 275 M

Market Context

Senior Management

Jim McAlister
President & CEO
Kris Jenner
Founder
Mark Bussard
Founder and Managing Member

Sort

immunocore

HQ - United Kingdom

Biotechnology

2 Mar 2020

Investment Date

£ 101 M

Deal Value

atea pharmaceuticals inc

HQ - United States

Pharmaceuticals

20 May 2020

Investment Date

£ 175 M

Deal Value

everest medicines ltd

HQ - China

Pharmaceuticals

5 Jun 2020

Investment Date

£ 245 M

Deal Value

cerevel therapeutics

HQ - United States

Biotechnology

Pharmaceuticals

28 Oct 2020

Investment Date

£ 1.00 B

Deal Value

kindbody

HQ - United States

Health Care Services

8 Jul 2020

Investment Date

£ 25 M

Deal Value

honor

HQ - United States

Digital Services

27 Oct 2020

Investment Date

£ 107 M

Deal Value

immuneering corporation

HQ - United States

Pharmaceuticals

5 Jan 2021

Investment Date

£ 44 M

Deal Value

xilio therapeutics

HQ - United States

Biotechnology

24 Feb 2021

Investment Date

£ 64 M

Deal Value

caris life sciences

HQ - United States

Biotechnology

11 May 2021

Investment Date

10%

Stake

£ 589 M

Deal Value

aadi bioscience inc

HQ - United States

Pharmaceuticals

26 Aug 2021

Investment Date

100%

Stake

n/a

Deal Value

eqrx

HQ - United States

Pharmaceuticals

2 Dec 2021

Investment Date

100%

Stake

£ 2.62 B

Deal Value

cincor pharma

HQ - United States

Biotechnology

12 Oct 2021

Investment Date

£ 104 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy